These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4402874)

  • 21. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 22. Pressor effect of beta blocking agents in rats.
    Regoli D; Regoli U; Gysling E
    Can J Physiol Pharmacol; 1972 Mar; 50(3):207-14. PubMed ID: 4402339
    [No Abstract]   [Full Text] [Related]  

  • 23. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
    Bassenge E; Kucharczyk M; Holtz J; Stoian D
    Pflugers Arch; 1972; 332(1):40-55. PubMed ID: 4401667
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacology of M & B 17803A in man and dog.
    Briant RH; Dollery CT; Fenyvesi T; George CF
    Br J Pharmacol; 1971 Oct; 43(2):468P-469P. PubMed ID: 4400577
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of -adrenergic blocking agents in presence of adrenergic tone.
    Elharrar V; Nadeau RA
    Can J Physiol Pharmacol; 1972 May; 50(5):381-8. PubMed ID: 4402699
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of some -adrenergic blocking agents on the acetylcholine content of heart. An experimental study in mice.
    Khanna NK
    Eur J Pharmacol; 1972 Feb; 17(2):309-11. PubMed ID: 4402099
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular effects of M & B 17803A in man.
    Leary WP; Coleman AJ
    S Afr Med J; 1972 Aug; 46(34):1202-3. PubMed ID: 4403479
    [No Abstract]   [Full Text] [Related]  

  • 28. [Quantitative comparison of the effects of various beta-adrenergic receptor antagonists in healthy subjects at rest and during infusions of isoproterenol].
    Bender F; Sieger W; Dotterweich K
    Arztl Forsch; 1969 Nov; 23(11):359-65. PubMed ID: 4391417
    [No Abstract]   [Full Text] [Related]  

  • 29. [Efficiency of myocardial performance and oxidation of exogenous 14C-substrates under the influence of beta-receptor stimulating and blocking agents, as compared with other cardioactive drugs].
    Range H; Bischoff M; Siess M
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):432-3. PubMed ID: 4397506
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of practolol, a new adrenergic receptor blocking agent on cardiovascular responses.
    Thompson EB
    J Pharm Sci; 1972 Apr; 61(4):573-6. PubMed ID: 4401257
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacological studies on the combination of a coronary dilator with a beta-receptor blocking agent].
    Kadatz R; Diederen W
    Arzneimittelforschung; 1972 Sep; 22(9):1449-54. PubMed ID: 4405011
    [No Abstract]   [Full Text] [Related]  

  • 32. Selective metabolic and cardiovascular beta receptor antagonism in the rat.
    Stanton HC
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):246-58. PubMed ID: 4401080
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
    Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
    Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of propranolol, oxprenolol, and practolol on denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br Heart J; 1971 Jul; 33(4):614-5. PubMed ID: 4397631
    [No Abstract]   [Full Text] [Related]  

  • 36. [Selective beta-blocking action of practolol (ICI 50.172)].
    Novelli GP; Pagni E; Cortesini C; Pagliai P; Francini R
    Minerva Anestesiol; 1969 Dec; 35(12):1286-94. PubMed ID: 4394406
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative studies on the effect of 2 beta receptor blockaders on elevated blood pressure and kidney function].
    Anlauf M; Heimsoth V; Ulrych M; Bock KD
    Verh Dtsch Ges Inn Med; 1969; 75():169-72. PubMed ID: 4395389
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemodynamic effects of beta-receptor blocking drugs during nitrous oxide-halothane anaesthesia.
    Stephen GW; Davie IT; Scott DB
    Br J Anaesth; 1971 Apr; 43(4):320-5. PubMed ID: 4396861
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological studies with tiprenolol and propranolol in man.
    Kesteloot H; Sluyts R; Floor-Wieringa A; van Strik R
    Eur J Pharmacol; 1973 Mar; 21(3):257-63. PubMed ID: 4145318
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.